Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-05
2005-04-05
Shameem, Golam M M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S229000, C548S243000, C549S429000, C549S475000, C514S376000, C514S473000
Reexamination Certificate
active
06875784
ABSTRACT:
The present invention provides certain [3.1.0] bicyclic oxazolidinone derivatives of Formulea I and II, described herein, or pharmaceutically acceptable salts or prodrugs thereof that are antibacterial agents, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
REFERENCES:
patent: 4183857 (1980-01-01), Kollmeyer
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4837028 (1989-06-01), Allen
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5023252 (1991-06-01), Hseih
patent: 6124334 (2000-09-01), Hutchinson
patent: 6255304 (2001-07-01), Hester et al.
patent: 6342513 (2002-01-01), Hester et al.
patent: 6451345 (2002-09-01), Percel et al.
patent: 6605609 (2003-08-01), Barbachyn et al.
patent: 6642238 (2003-11-01), Hester, Jr.
patent: 6689769 (2004-02-01), Gordeev et al.
patent: 20020086900 (2002-07-01), Perrault et al.
patent: 0807630 (1996-02-01), None
patent: WO 9323384 (1993-11-01), None
patent: WO 9507271 (1995-03-01), None
patent: WO 9601262 (1996-01-01), None
patent: WO 9854161 (1998-12-01), None
patent: WO 9941244 (1999-08-01), None
patent: WO 9964417 (1999-12-01), None
patent: WO 0010566 (2000-03-01), None
patent: WO 0021960 (2000-04-01), None
patent: WO 0146185 (2001-06-01), None
patent: WO 0181350 (2001-11-01), None
patent: WO 0206278 (2002-01-01), None
patent: WO 03027083 (2003-04-01), None
Kenneth E. Avis, DSc, Remington's Pharmaceutical Sciences, Parenteral Preparations, Mace Publishing Company, Philadelphia, PA, 17thed., 1461-1487 (1985).
Advanced Organic Chemistry, 4thedition, Chapter 4, J. March, John Wiley & Sons, New York, “Stereochemistry”, (1992) 94-130.
M. R. Barbachyn, et al., J. Med. Chem (1996), 39,680-685 XP000574382.
K. E. Brighty and M.J. Castaldi, in Synlett p. 1097-1099 (Nov. 1996).
S. L. Buchwald, et al., J. Am. Chem. Soc. 122(7), 1360-1370 (2000).
N. K. Chaudhuri and T. J. Ball, in J. Org. Chem., vol. 47, 5196-5198 (1982).
Fabiano et al., Synthesis, p. 190-192 (1987).
P. J. Kocienski, “Protecting Groups”; Publisher: George Thieme Verlag: Stuttgart, 195-199 (1994).
Q. Lin, et al., J. Med. Chem. (1996), 39, 3070-3088 XP-002064518.
Mahmood et al., J. Org. Chem., 63, 3333-3336 (1998).
C. Pedregal, et al., Tet. Lett. 38, 2133-2136, (1997).
Reusch in Reduction, Augustine Ed.; Marcel Dekkar: New York, 171-211 (1968).
Rylander, Hydrogenation Methods; Academic Press: New York, 104-116 (1985).
Zoltewicz, in Top, Curr. Chem. Chem. vol. 59, 33-64 (1975).
Gordeev Mikhail Fedor
Patel Dinesh Vinoobhai
Renslo Adam
Engelmann John H.
Pharmacia & Upjohn Company
Shameem Golam M M
Young Robert N.
LandOfFree
Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3418438